Next Article in Journal
Bulgecin A: The Key to a Broad‐Spectrum Inhibitor That Targets Lytic Transglycosylases
Next Article in Special Issue
Erythromycin Modification That Improves Its Acidic Stability while Optimizing It for Local Drug Delivery
Previous Article in Journal
Diminished Antimicrobial Peptide and Antifungal Antibiotic Activities against Candida albicans in Denture Adhesive
Previous Article in Special Issue
Fused-Ring Oxazolopyrrolopyridopyrimidine Systems with Gram-Negative Activity
Article Menu

Export Article

Open AccessArticle
Antibiotics 2017, 6(1), 7; doi:10.3390/antibiotics6010007

Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis

Consiglio Nazionale delle Ricerche (C.N.R.), Istituto di Chimica del Riconoscimento Molecolare; Via L. Mancinelli 7, I-20131 Milano, Italy
Dipartimento di Chimica, Materiali ed Ingegneria Chimica del Politecnico, Via Mancinelli 7, I-20131 Milano, Italy
OLON S.p.A, Strada Rivoltana 6/7, 20090 Rodano, Italy
Author to whom correspondence should be addressed.
Academic Editor: Naresh Kumar
Received: 20 December 2016 / Revised: 22 January 2017 / Accepted: 30 January 2017 / Published: 8 February 2017
(This article belongs to the Special Issue Antibiotic Synthesis)
View Full-Text   |   Download PDF [4430 KB, uploaded 10 February 2017]   |  


Lipiarmycin A3 and tiacumicin B possess the same chemical structure and have been considered identical till recently, when some authors have suggested the possibility of a minor difference between the chemical structures of the two antibiotics. In this work we performed a comparative X-ray analysis of lipiarmycin A3 and tiacumicin B. Although the commercial samples of the aforementioned compounds crystallize into two different crystal systems—evidently due to the different crystallization conditions—their chemical structures are identical. These results confirmed the previous assigned chemical structure of lipiarmycin A3 and its absolute configuration as well as its co-identity with the chemical structure of tiacumicin B, providing the definitive proof that these pharmaceutical compounds are identical in all respects. View Full-Text
Keywords: actinomycetes; antibiotic; fidaxomicin; lipiarmycin A3; tiacumicin B; X-ray analysis actinomycetes; antibiotic; fidaxomicin; lipiarmycin A3; tiacumicin B; X-ray analysis

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Serra, S.; Malpezzi, L.; Bedeschi, A.; Fuganti, C.; Fonte, P. Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis. Antibiotics 2017, 6, 7.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top